US Stock MarketDetailed Quotes

HBI Hanesbrands

Watchlist

4.760
+0.170+3.70%

Close May 2 16:00 ET

4.820
+0.060+1.26%

Post 19:59 ET

1.68BMarket Cap-5.23P/E (TTM)

Hanesbrands Stock Forum

Kitty Stocks

Mar 4 00:34

$Hanesbrands (HBI.US)$ ready to gap up soon.

Wacho-el-Wero

Aug 17, 2024 03:20

8 🤑🤑

$Hanesbrands (HBI.US)$

Trytosaveabit

Jun 5, 2024 23:57

Would thought this news woulda got more attention?

$Hanesbrands (HBI.US)$ Hanesbrands has agreed to sell the Champion brand to Authentic Brands Group for $1.2 billion. The deal could increase to $1.5 billion if a contingent cash consideration of up to $300 million is fulfilled. This requires the brand to reach performance goals after the sale.
Hanesbrands notes that it will receive net proceeds of $900 million from this deal. The company says that it intends to use all of the funds gained from ...

Young Irish

May 25, 2024 06:43

Reverse split..

$Hanesbrands (HBI.US)$ needs to do as other companies have recently and prepare to reverse split the stock.. this will be beneficial for many reasons.. mainly they will be doing it on their own terms..
if the company waits until were under a dollar and is forced, its seen as weaknes and reactionary..
we need to be proactive.. ive added a link for an article posted on nasdaq’s website.
The Impact of Reverse Splits on Low-Priced Stocks
everyone that owns shares should send the sto...

Young Irish

Apr 3, 2024 00:41

Champion Sale

$Hanesbrands (HBI.US)$ has initially agreed to sell Champion for a little more than 1 Bil.. this would be a good time to use the cash from the sale to pay down debt..

Wacho-el-Wero

Mar 29, 2024 02:07

We been on the moon

$Hanesbrands (HBI.US)$

Wacho-el-Wero

Mar 21, 2024 02:51

You make me feel rich; when will dividend kick in?

$Hanesbrands (HBI.US)$

Moomoo AI

Mar 17, 2024 22:18

Hanesbrands' declining revenue and negative growth outlook may pose a risk to the share price. The current P/S ratio suggests potential investors may be paying a premium for the stock, risking future disappointment if the P/S falls in line with the negative growth outlook.